Perrigo Company plc Senior Notes
Perrigo Company plc (PRGO) had Senior Notes of $2.27 billion as of 2025-06-28, per its 10-Q filed 2025-08-06.
Financial Statements › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:SeniorNotes · last filed 2025-08-06
- 2025-06-28: Senior Notes $2.27B.
- 2025-03-29: Senior Notes $2.24B.
- 2024-12-31: Senior Notes $2.22B.
- 2024-09-28: Senior Notes $3.35B.
| Period end | Senior Notes | Senior Notes as first filed |
|---|---|---|
| 2025-06-28 | $2.27B 10-Q · filed 2025-08-06 | |
| 2025-03-29 | $2.24B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $2.22B 10-Q · filed 2025-08-06 | |
| 2024-09-28 | $3.35B 10-Q · filed 2024-11-06 | |
| 2024-06-29 | $2.24B 10-Q · filed 2024-08-02 | |
| 2024-03-30 | $2.24B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $2.24B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $2.54B 10-Q · filed 2023-11-07 | |
| 2023-07-01 | $2.54B 10-Q · filed 2023-08-08 | |
| 2023-04-01 | $2.54B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.54B 10-K · filed 2024-02-27 | |
| 2022-10-01 | $2.54B 10-Q · filed 2022-11-08 | |
| 2022-07-02 | $2.54B 10-Q · filed 2022-08-09 | |
| 2022-04-02 | $2.91B 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $2.91B 10-K · filed 2023-02-28 | |
| 2021-10-02 | $2.92B 10-Q · filed 2021-11-12 | |
| 2021-07-03 | $2.92B 10-Q · filed 2021-08-11 | |
| 2021-04-03 | $2.92B 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.92B 10-K · filed 2022-03-01 | |
| 2020-09-26 | $2.92B 10-Q · filed 2020-11-05 | |
| 2020-06-27 | $3.50B 10-Q · filed 2020-08-05 | |
| 2020-03-28 | $2.75B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $2.75B 10-K · filed 2021-03-01 | |
| 2019-09-28 | $2.75B 10-Q · filed 2019-11-06 | |
| 2019-06-29 | $2.75B 10-Q · filed 2019-08-08 | |
| 2019-03-30 | $2.89B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.89B 10-K · filed 2020-02-27 | |
| 2018-09-29 | $2.90B 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.90B 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.91B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.91B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $3.26B 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $3.23B 10-Q · filed 2017-08-10 | |
| 2017-04-01 | $5.38B 10-Q · filed 2017-05-30 | |
| 2016-12-31 | $5.37B 10-K · filed 2018-03-01 | |
| 2016-10-01 | $5.43B 10-Q/A · filed 2017-05-23 | |
| 2016-07-02 | $5.92B 10-Q/A · filed 2017-05-22 | |
| 2016-04-02 | $5.94B 10-Q/A · filed 2017-05-22 | |
| 2015-12-31 | $4.70B 10-Q/A · filed 2017-05-23 | |
| 2015-09-26 | $4.72B 10-Q · filed 2015-11-02 | |
| 2015-06-27 | $4.70B 10-K · filed 2018-03-01 | $4.72B 10-K · filed 2015-08-13 |
| 2015-03-28 | $3.89B 10-Q · filed 2015-04-29 | |
| 2014-12-27 | $3.89B 10-Q · filed 2015-02-05 | |
| 2014-09-27 | $2.29B 8-K · filed 2014-11-20 | |
| 2014-06-28 | $2.30B 10-KT · filed 2016-02-25 | $2.29B 10-K · filed 2014-08-14 |
| 2014-03-29 | $2.29B 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $2.29B 10-Q · filed 2014-02-06 | |
| 2013-11-08 | $2.30B 10-K · filed 2023-02-28 | $2.28B 10-K · filed 2014-08-14 |
| 2013-06-29 | $1.56B 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |